The first Medifast trade was made in Q2 2021.
Since then Ray Dalio bought shares four more times and sold shares on eight occasions. The investor completely sold their stake between Q4 2023 and Q2 2024.
Avg closing price
Price range
Sold -17.5 Thousand shares
Q2 2024
Avg closing price
$26.66
Price range
$19.49
-
$37.51
Sold 12.3% shares (-2.45 Thousand shares)
Q1 2024
Avg closing price
$48.43
Price range
$34.57
-
$70.23
Sold 9.2% shares (-2.02 Thousand shares)
Q4 2023
Avg closing price
$69.66
Price range
$62.17
-
$76.46
Increased shares by 4.9% (+1.02 Thousand shares)
Q3 2023
Avg closing price
$88.72
Price range
$74.85
-
$107.06
Sold 5.7% shares (-1.27 Thousand shares)
Q2 2023
Avg closing price
$89.03
Price range
$78.70
-
$102.49
Sold 2.8% shares (-648 shares)
Q1 2023
Avg closing price
$110.82
Price range
$97.09
-
$130.31
Sold 24.9% shares (-7.58 Thousand shares)
Q4 2022
Avg closing price
$116.44
Price range
$103.38
-
$126.05
Sold 31.1% shares (-13.7 Thousand shares)
Q3 2022
Avg closing price
$143.29
Price range
$108.36
-
$187.67
Increased shares by 45.0% (+13.7 Thousand shares)
Q2 2022
Avg closing price
$178.92
Price range
$157.78
-
$194.92
Increased shares by 29.9% (+7.01 Thousand shares)
Q1 2022
Avg closing price
$188.52
Price range
$163.59
-
$219.02
Increased shares by 14.9% (+3.04 Thousand shares)
Q4 2021